In addition, CXCL5 and CXCR2 ligand-receptor interaction drive infiltration of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), promoting cancer metastasis in prostate cancer32,33. Here, CXCR2 is linked to neoplasm.